Method Development And Validation For Simultaneous Estimation Of Amlodipine Besylate And Olmesartan In Bulk And Pharmaceutical Formulation By Rp-Hplc
Main Article Content
Abstract
Objective: To develop and validate the RP-HPLC method for simultaneous estimation of amlodipine besylate and
Olmesartan in bulk and pharmaceutical formulation. Materials and methods: Simultaneous estimation of amlodipine
and Olmesartan were carried out by RP- HPLC using Acetonitrile: Phosphate buffer (pH 4.0) (58:42) and column
Phenomenex Luna C-18 (150×4.6mm, 5μ) as a stationary phase and peak was observed at 235nm which was
selected as a wavelength for quantitative estimation. Results: Method was developed and this method was
validated as per ICH guidelines for specificity, linearity, precision, accuracy, robustness and ruggedness studies.
Conclusion: All the validated parameters were within the limits. The method was found to be suitable for the
estimation of amlodipine besylate and Olmesartan in bulk and pharmaceutical formulation.
Article Details
All articles published in NVEO are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.